Soleno Therapeutics, Inc. · NASDAQ:SLNO

Wellington Management Group LLP reported a 8.60% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Wellington Management Group LLP reported a 8.60% stake in Soleno Therapeutics, Inc., 4,426,781 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
8.60%
Shares
4,426,781
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Wellington Management Group LLP8.60%4,426,781
Wellington Group Holdings LLP8.60%4,426,781
Wellington Investment Advisors Holdings LLP8.60%4,426,781
Wellington Management Company LLP8.30%4,426,781

Source

View original at SEC

Related